2022
DOI: 10.1016/j.nerep.2022.100121
|View full text |Cite
|
Sign up to set email alerts
|

Optic neuropathy after COVID-19 vaccination: Case report and systematic review

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

2
6
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 7 publications
(8 citation statements)
references
References 60 publications
2
6
0
Order By: Relevance
“…Critical visual loss occurs suddenly with pain, and only 0.4% of patients develop symptoms in both eyes simultaneously, 5,7,9 as in our case. VEP studied the visual function, and magnetic resonance imaging considered as a sensitive indicator of demyelination in ON, 10,11 as in our patient.…”
Section: Discussionsupporting
confidence: 49%
See 4 more Smart Citations
“…Critical visual loss occurs suddenly with pain, and only 0.4% of patients develop symptoms in both eyes simultaneously, 5,7,9 as in our case. VEP studied the visual function, and magnetic resonance imaging considered as a sensitive indicator of demyelination in ON, 10,11 as in our patient.…”
Section: Discussionsupporting
confidence: 49%
“…Only a total of 8 reports on 9 patients have been published to date, 8 of 9 were females. 5,7,9,11 Our case is the third case of post-COVID-19 vaccination optic neuropathy in a male. The cases affect young females more, with improvement with IV methylprednisolone therapy for most of them, after 6-14 days after the COVID-19 vaccination; meanwhile, our patient is a male who developed ON after 10 days of vaccination and did not respond to IV methylprednisolone therapy.…”
Section: Discussionmentioning
confidence: 68%
See 3 more Smart Citations